Kala Pharmaceuticals, Inc. (KALA)
NASDAQ: KALA · IEX Real-Time Price · USD
6.76
-0.07 (-1.02%)
At close: Jul 19, 2024, 4:00 PM
6.68
-0.08 (-1.18%)
Pre-market: Jul 20, 2024, 9:27 AM EDT
Kala Pharmaceuticals Market Cap
Kala Pharmaceuticals has a market cap or net worth of $19.04 million as of July 22, 2024. Its market cap has decreased by -47.26% in one year.
Market Cap
19.04M
Enterprise Value
7.12M
1-Year Change
-47.26%
Ranking
Category
Stock Price
$6.76
Market Cap Chart
Since July 20, 2017, Kala Pharmaceuticals's market cap has decreased from $430.50M to $19.04M, a decrease of -95.58%. That is a compound annual growth rate of -35.94%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 19, 2024 | 19.00M | 0.53% |
| Dec 29, 2023 | 18.90M | -67.36% |
| Dec 30, 2022 | 57.90M | -26.99% |
| Dec 31, 2021 | 79.30M | -79.14% |
| Dec 31, 2020 | 380.20M | 198.20% |
| Dec 31, 2019 | 127.50M | -22.87% |
| Dec 31, 2018 | 165.30M | -63.54% |
| Dec 29, 2017 | 453.40M | 5.32% |
View and export this data all the way back to 2017.
Sign Up Today.
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alterity Therapeutics | 19.98M |
| NeurAxis | 19.81M |
| Bullfrog AI | 19.39M |
| Vincerx Pharma | 19.29M |
| MEI Pharma | 19.06M |
| Cara Therapeutics | 18.84M |
| iBio, Inc. | 18.54M |
| Aspira Women's Health | 18.43M |